Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA)

CUSIP: 687604108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
47,863,907
Total 13F shares
31,038,311
Share change
+6,437,607
Total reported value
$606,624,310
Price per share
$19.39
Number of holders
66
Value change
+$125,781,752
Number of buys
45
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 687604108?
CUSIP 687604108 identifies ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA) as of Q4 2024

As of 31 Dec 2024, Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,038,311 shares. The largest 10 holders included FMR LLC, Fairmount Funds Management LLC, VR Adviser, LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, COMMODORE CAPITAL LP, PRICE T ROWE ASSOCIATES INC /MD/, BRAIDWELL LP, JANUS HENDERSON GROUP PLC, and PERCEPTIVE ADVISORS LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.